BIOMAT Database Logo BIOMAT Database Logo

[Experiences with the oral antidiabetic agent, Glurenorm, in diabetics with kidney diseases]. 1975

A Uglesic, and N Ljahnicky

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

A Uglesic, and N Ljahnicky
[Clinical experiences with administration of oral antidiabetic agent Buformin].
April 1971, Casopis lekaru ceskych,
A Uglesic, and N Ljahnicky
Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period.
February 1957, The Journal of the Tennessee State Medical Association. Tennessee State Medical Association,
A Uglesic, and N Ljahnicky
[Glurenorm a new peroral antidiabetic agent belonging to the group of sulfonylurea compounds].
January 1976, Medicinski arhiv,
A Uglesic, and N Ljahnicky
[Experiences in ambulatory treatment of female diabetics with oral contraceptive agent, Ovosiston].
February 1971, Zeitschrift fur arztliche Fortbildung,
A Uglesic, and N Ljahnicky
[Clinical experience with Glurenorm in type 2 diabetics with renal insufficiency].
August 1988, Vnitrni lekarstvi,
A Uglesic, and N Ljahnicky
[Combined therapy with insulin/gliquidone (Glurenorm) in type 2 diabetes after treatment failure using oral antidiabetic agents].
October 1992, Vnitrni lekarstvi,
A Uglesic, and N Ljahnicky
[Studies and experiences with the oral antidiabetic Haury].
June 1959, Medizinische Monatsschrift,
A Uglesic, and N Ljahnicky
[First experiences with the new oral antidiabetic invenol].
May 1957, Orvosi hetilap,
A Uglesic, and N Ljahnicky
[Glimepiride--an oral antidiabetic agent].
January 2003, Medicinski arhiv,
A Uglesic, and N Ljahnicky
[EXPERIENCES WITH REDUL, A NEW ORAL ANTIDIABETIC].
October 1964, Medizinische Klinik,
Copied contents to your clipboard!